Breaking News Instant updates and real-time market news.

ADMP

Adamis Pharmaceuticals

$4.55

-0.2 (-4.21%)

15:34
11/14/17
11/14
15:34
11/14/17
15:34

Adamis Pharmaceuticals options imply 18.5% move in share price post-earnings, above median historical move

Pre-earnings options volume in Adamis Pharmaceuticals is normal with calls leading puts 18:1. Implied volatility suggests the market is anticipating a move near 18.5%, or 86c, after results are released. Median move over the past eight quarters is 2.4%.

ADMP Adamis Pharmaceuticals
$4.55

-0.2 (-4.21%)

01/24/17
MAXM
01/24/17
NO CHANGE
Target $10
MAXM
Buy
Adamis undervalued if able to take just 10% of EpiPen market, says Maxim
After privately-held Kaleo announced a "complex pricing strategy" for their EpiPen-like device, Auvi-Q, which is returning to the market, Maxim analyst Jason Kolbert said he views Adamis' (ADMP) PFS to be a better, more user friendly product than Mylan's (MYL) EpiPen, Impax Labs' (IPXL) Adrenaclick and Kaleo's AuviQ. If Adamis can acquire just 10% market share, which he believes is at the low end, the shares are undervalued, Kolbert tells investors. He keeps a Buy rating and $10 price target on Adamis shares.
06/15/17
MAXM
06/15/17
NO CHANGE
Target $10
MAXM
Buy
Adamis Pharmaceuticals partnering could be next, says Maxim
Following FDA approval of its epinephrine syringe approval, Maxim said Adamis Pharmaceuticals is now exploring commercialization options and in discussions with potential partners. At just over a $100M in market capitalization, cash on the balance sheet and an alternative to EpiPen, the firm sees the story getting better and reiterates its Buy rating and $10 pic target.
09/12/17
RAJA
09/12/17
INITIATION
Target $7
RAJA
Outperform
Adamis Pharmaceuticals initiated with an Outperform at Raymond James
Raymond James analyst Elliot Wilbur initiated Adamis Pharmaceuticals with an Outperform and a $7 price target. Wilbur said Adamis' near-term value proposion is the commercialization of the FDA approved EpiPen alternative known as Symjepi via an expected marketing partnership in 2H17 or early 2018.
10/04/17
RILY
10/04/17
INITIATION
Target $9.5
RILY
Buy
Adamis Pharmaceuticals re-initiated with a Buy at B. Riley
B. Riley analyst Andrew D'Silva re-initiated coverage of Adamis Pharmaceuticals (ADMS) with a Buy rating and $9.50 price target. The analyst believes the company is favorably positioned to establish a marketing partnership as an alternative to Mylan's (MYL) EpiPen.

TODAY'S FREE FLY STORIES

TXT

Textron

$66.81

0.14 (0.21%)

06:33
07/18/18
07/18
06:33
07/18/18
06:33
Hot Stocks
Textron sees one-time gain of approximately $400M in Q3 »

Textron expects a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ANDX

Andeavor Logistics

$42.21

-0.29 (-0.68%)

06:32
07/18/18
07/18
06:32
07/18/18
06:32
Downgrade
Andeavor Logistics rating change  »

Andeavor Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PAA

Plains All American

$23.00

-0.39 (-1.67%)

06:32
07/18/18
07/18
06:32
07/18/18
06:32
Upgrade
Plains All American rating change  »

Plains All American…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

TXT

Textron

$66.81

0.14 (0.21%)

06:32
07/18/18
07/18
06:32
07/18/18
06:32
Hot Stocks
Textron raises FY18 cash flow view to $750M-$850M »

Up $50M from prior…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TXT

Textron

$66.81

0.14 (0.21%)

06:31
07/18/18
07/18
06:31
07/18/18
06:31
Earnings
Textron raises FY18 cont ops EPS view to $3.15-$3.35 from $2.95-$3.15 

FY18 consensus $3.16.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

CEA

China Eastern Airlines

$32.20

-0.29 (-0.89%)

06:30
07/18/18
07/18
06:30
07/18/18
06:30
Upgrade
China Eastern Airlines rating change  »

China Eastern Airlines…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXT

Textron

$66.81

0.14 (0.21%)

06:30
07/18/18
07/18
06:30
07/18/18
06:30
Earnings
Textron reports Q2 cont ops EPS 87c, consensus 70c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

EADSY

Airbus

$0.00

(0.00%)

, UTX

United Technologies

$130.71

1.73 (1.34%)

06:29
07/18/18
07/18
06:29
07/18/18
06:29
Periodicals
Airbus says Pratt & Whitney catching up on engine delays, Reuters reports »

Airbus (EADSY) said…

EADSY

Airbus

$0.00

(0.00%)

UTX

United Technologies

$130.71

1.73 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

AIRYY

Air China

$0.00

(0.00%)

06:29
07/18/18
07/18
06:29
07/18/18
06:29
Downgrade
Air China rating change  »

Air China downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLX

Clorox

$135.00

0.71 (0.53%)

06:26
07/18/18
07/18
06:26
07/18/18
06:26
Downgrade
Clorox rating change  »

Goldman downgrades Clorox…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

UHS

Universal Health

$114.95

0.23 (0.20%)

06:26
07/18/18
07/18
06:26
07/18/18
06:26
Downgrade
Universal Health rating change  »

Universal Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

NVS

Novartis

$78.72

0.15 (0.19%)

, PFE

Pfizer

$37.67

0.28 (0.75%)

06:24
07/18/18
07/18
06:24
07/18/18
06:24
Periodicals
Novartis puts brakes on price hikes in the U.S. for 2018, Reuters reports »

Novartis (NVS) CEO Vas…

NVS

Novartis

$78.72

0.15 (0.19%)

PFE

Pfizer

$37.67

0.28 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

  • 10

    Sep

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

, TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

06:23
07/18/18
07/18
06:23
07/18/18
06:23
Periodicals
Toshiba could face investor complaints for 2015 accounting scandal, Reuters says »

The 9th U.S. Circuit…

TOSBF

Toshiba, also use TOSYY

$0.00

(0.00%)

TOSYY

Toshiba, also use TOSBF

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

HCSG

Healthcare Services

$42.38

-0.3297 (-0.77%)

06:20
07/18/18
07/18
06:20
07/18/18
06:20
Downgrade
Healthcare Services rating change  »

Healthcare Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

LOW

Lowe's

$100.28

0.69 (0.69%)

06:20
07/18/18
07/18
06:20
07/18/18
06:20
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZZA

Papa John's

$51.54

0.11 (0.21%)

06:19
07/18/18
07/18
06:19
07/18/18
06:19
Periodicals
Lawyer for Papa John's founder calls for probe into his removal, NY Times says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

KL

Kirkland Lake Gold

$22.64

-0.41 (-1.78%)

06:17
07/18/18
07/18
06:17
07/18/18
06:17
Downgrade
Kirkland Lake Gold rating change  »

Kirkland Lake Gold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

VNE

Veoneer

$49.78

1.31 (2.70%)

06:17
07/18/18
07/18
06:17
07/18/18
06:17
Initiation
Veoneer initiated  »

Mizuho starts 'key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCAR

Paccar

$63.22

0.64 (1.02%)

06:17
07/18/18
07/18
06:17
07/18/18
06:17
Downgrade
Paccar rating change  »

Paccar downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RYN

Rayonier

$37.73

-0.25 (-0.66%)

06:16
07/18/18
07/18
06:16
07/18/18
06:16
Downgrade
Rayonier rating change  »

Rayonier downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

EXR

Extra Space Storage

$94.67

-2.05 (-2.12%)

06:16
07/18/18
07/18
06:16
07/18/18
06:16
Downgrade
Extra Space Storage rating change  »

Extra Space Storage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

FB

Facebook

$209.99

2.66 (1.28%)

06:16
07/18/18
07/18
06:16
07/18/18
06:16
Periodicals
Facebook exec apologizes to pro-Trump vloggers at hearing, BI reports »

Facebook VP for Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 18

    Sep

CF

CF Industries

$42.72

0.475 (1.12%)

06:16
07/18/18
07/18
06:16
07/18/18
06:16
Upgrade
CF Industries rating change  »

CF Industries upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

WFC

Wells Fargo

$56.57

-0.44 (-0.77%)

06:16
07/18/18
07/18
06:16
07/18/18
06:16
Conference/Events
Wells Fargo management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 12

    Apr

  • 13

    Jul

  • 15

    Oct

TWTR

Twitter

$44.70

0.45 (1.02%)

06:15
07/18/18
07/18
06:15
07/18/18
06:15
Downgrade
Twitter rating change  »

Twitter downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.